Cargando…

Cerebrovascular insulin receptors are defective in Alzheimer’s disease

Central response to insulin is suspected to be defective in Alzheimer’s disease. As most insulin is secreted in the bloodstream by the pancreas, its capacity to regulate brain functions must, at least partly, be mediated through the cerebral vasculature. However, how insulin interacts with the blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leclerc, Manon, Bourassa, Philippe, Tremblay, Cyntia, Caron, Vicky, Sugère, Camille, Emond, Vincent, Bennett, David A, Calon, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897197/ https://www.ncbi.nlm.nih.gov/pubmed/36280236 http://dx.doi.org/10.1093/brain/awac309

Ejemplares similares

Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Reveret, Louise, et al.
Publicado: (2023)

Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Louise, Reveret, et al.
Publicado: (2023)

Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Reveret, Louise, et al.
Publicado: (2023)

Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer’s Disease, Without Altering Amyloid-β and Tau Pathologies
por: Fanet, Hortense, et al.
Publicado: (2021)

Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology
por: Tournissac, Marine, et al.
Publicado: (2018)

Evidence of Filamin A loss of solubility at the prodromal stage of neuropathologically-defined Alzheimer’s disease
por: Aumont, Etienne, et al.
Publicado: (2022)

Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice
por: Arsenault, Dany, et al.
Publicado: (2020)

Can insulin signaling pathways be targeted to transport Aβ out of the brain?
por: Vandal, Milene, et al.
Publicado: (2015)

Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
por: Tremblay, Cyntia, et al.
Publicado: (2017)

Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model
por: Landry, Olivier, et al.
Publicado: (2023)

Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells
por: Levert, Stéphanie, et al.
Publicado: (2022)

Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
por: Tournissac, Marine, et al.
Publicado: (2021)

IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
por: St-Amour, Isabelle, et al.
Publicado: (2014)

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease
por: Bories, Cyril, et al.
Publicado: (2017)

DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice
por: Arsenault, Dany, et al.
Publicado: (2011)

Can Natural Products Exert Neuroprotection without Crossing the Blood–Brain Barrier?
por: Leclerc, Manon, et al.
Publicado: (2021)

Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits
por: Ohta, Yasuyuki, et al.
Publicado: (2014)

Sex-Dependent Alterations in Social Behaviour and Cortical Synaptic Activity Coincide at Different Ages in a Model of Alzheimer’s Disease
por: Bories, Cyril, et al.
Publicado: (2012)

Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation
por: Tournissac, Marine, et al.
Publicado: (2019)

Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
por: Reveret, L., et al.
Publicado: (2023)

High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Bosoi, Cristina R., et al.
Publicado: (2020)

Internalization of targeted quantum dots by brain capillary endothelial cells in vivo
por: Paris-Robidas, Sarah, et al.
Publicado: (2015)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Brain insulin signaling and cerebrovascular disease in human postmortem brain
por: Arvanitakis, Zoe, et al.
Publicado: (2021)

Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2021)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)
por: Belleville, Sylvie, et al.
Publicado: (2019)

Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
por: Delay, Charlotte, et al.
Publicado: (2011)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan, Jing, et al.
Publicado: (2013)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Evaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy Samples
por: Bourassa, Sylvie, et al.
Publicado: (2015)

The Nuclear Receptor PPARγ as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease
por: Nicolakakis, Nektaria, et al.
Publicado: (2010)

Cognitive and cerebrovascular improvements following kinin B(1) receptor blockade in Alzheimer’s disease mice
por: Lacoste, Baptiste, et al.
Publicado: (2013)

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

Insulin-like growth factor-1 in CNS and cerebrovascular aging
por: Sonntag, William E., et al.
Publicado: (2013)

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
por: Humpel, Christian
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tgckfik4d4agj6tufsa3hf770f